The 2026 ESC Guidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease, developed by the European Society of Cardiology (ESC) in collaboration with the European Renal Association (ERA), are the first guidelines dedicated to the management of cardiovascular disease (CVD) and chronic kidney disease (CKD). CKD is closely associated with several cardiovascular conditions, including coronary artery disease (CAD), heart failure (HF), arrhythmias, stroke, peripheral arterial disease (PAD), and sudden cardiac death (SCD). These guidelines emphasize an integrated cardiorenal approach focused on early CKD detection, cardiovascular risk reduction, and individualized treatment based on kidney function.
Click the button to explore the key recommendations from the guideline in detail.